Job Description

REQUIRED SKILLS

Master’s degree in a related Business discipline including Business Administration, Finance, Economics, or Public Health, plus four (4) years of relevant Pricing and Reimbursement industry experience strongly preferred. Will accept a Bachelor’s degree plus five (5) years of described experience. Experience must include 4 years for the majority of the following:

• Demonstrated understanding of payer environment, both US and globally, including coverage and reimbursement, value drivers, formulary management, health technologies assessment, and health policy
• Experience in developing Global payer policy and strategies.
• Demonstrated understanding of pharmaceutical product development or commercialization
• Demonstrated ability to develop deep therapeutic expertise
• Experience supporting Business and Development assessments
• Strong communication and influencing skills
• Ability to work under pressure within short timeframes

Additional Information

ABOUT THIS ROLE

The Associate Director, Global Value and Access – Business Development will assess worldwide acquisition and in-licensing opportunities across a variety of diseases/therapeutic areas. This successful candidate will report to the Head of Global Pricing and Access within the Value and Access team and will be responsible for developing price and access estimates and inform development of target product profiles and clinical development programs for all potential assets to be in-licensed or acquired by Biogen. The role involves partnering with Business Development, Corporate Strategy, Clinical Development, Regulatory, Legal, and Finance.

WHAT YOU’LL DO

• Conduct secondary research determining price levels of existing therapies and payer management, HTA review outcomes for relevant products, and burden of disease to inform price and market access estimates, inform target product profile and clinical trials development program
• Lead third party abbreviated payer and analog research, integrating product’s value proposition and supporting clinical information, to determine achievable price, including gross to net, and market access for specific (or, across) indication(s), and optimal evidence package and indication sequencing
• Develop pricing, market access, and gross-to-net assumptions for the forecast and financial model quantifying the business opportunity as part of the business development commercial evaluation.
• Align with the Corporate Strategy team on the overall commercial assumptions supporting the business case forecast.
• Represent the Global Value & Access team at the cross-functional business development diligence team meetings, and, when needed, at the various business development governing bodies, to support the price and market access estimates input into the broader commercial evaluation.
• Meet, when feasible and appropriate, with targeted companies’ management to discuss commercial insights and companies’ high level commercial assumptions
• Support executive commercial management, when required, by briefing them on the price and access recommendation and supporting rationale in preparation for the review of business case by the broader Executive team and Board of Directors